
DocGo to Provide Medical Transportation Services to Albany Stratton VA Medical Center
Under the contract, Ambulnz by DocGo will provide basic life support, advanced life support and critical care ambulance services for patients needing transportation to and from VA medical centers and community-based outpatient clinics in the Capital Region.
'As we look to grow our work with the VA, DocGo is proud to expand our tech-enabled medical transportation services to our country's veterans in Upstate New York,' said DocGo CEO Lee Bienstock. 'Our mission is to provide high quality, highly accessible care for all – and we are proud to assist the VA in clearing transportation barriers for American heroes to receive the healthcare they need at VA facilities.'
The Albany Stratton VA Medical Center main campus serves more than 50,000 veterans, primarily from the Albany area and its ten community-based outpatient clinics. The hospital has 150 inpatient beds and sees approximately 700 inpatient admissions and 450,000 outpatient visits a year.
DocGo began providing services on July 1, 2025.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com. To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit www.proactivecarenow.com.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the Company's plans, strategies, outcomes, and prospects, both business and financial, including the Company's provision of services under its contract with Albany Stratton VA Medical Center and the value of such contract. These statements are based on the beliefs and assumptions of the Company's management. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, outcomes, results or expectations. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. In some cases, these statements may be preceded by, followed by or include the words 'believes,' 'estimates,' 'expects,' 'projects,' 'forecasts,' 'may,' 'might,' 'will,' 'should,' 'could,' 'can,' 'would,' 'design,' 'potential,' 'seeks,' 'plans,' 'scheduled,' 'anticipates,' 'intends' or the negative of these terms or similar expressions. Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond the Company's control, and which may cause the Company's actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in the Company's forward-looking statements, including, but not limited to the following: the Company's ability to successfully implement its business strategy, including with respect to the provision of services under its contract with Albany Stratton VA Medical Center; the Company's reliance on and ability to maintain its contractual relationships with its healthcare provider partners and clients; the Company's ability to compete effectively in a highly competitive industry; the Company's ability to maintain existing contracts, including the contract with Albany Stratton VA Medical Center; the Company's reliance on government contracts; the Company's ability to effectively manage its growth; the Company's financial performance and future prospects; the Company's ability to deliver on its business strategies or models, plans and goals; the Company's ability to expand geographically; the Company's competitive position and opportunities, including its ability to realize the benefits from its operating model; and other risk factors included in the Company's filings with the Securities and Exchange Commission. The forward-looking statements made in this press release are based on events or circumstances as of the date on which the statements are made. The Company undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Will ICON PLC (ICLR) Benefit from R&D Spending?
Parnassus Investments, an investment management company, released the 'Parnassus Mid Cap Growth Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. The Russell Midcap Growth Index fell 7.12% in the first quarter, starting with a continuation of the late 2024 rally but later experiencing a sharp decline. The Fund (Investor Shares) fell -9.98% (net of fees) in the quarter, compared to the Russell Midcap Growth Index's -7.12% fall. Stock selection in Consumer Discretionary and Industrials contributed to the relative performance, while Communication Services and Health Care detracted. In addition, please check the fund's top five holdings to know its best picks in 2025. In its first-quarter 2025 investor letter, Parnassus Mid Cap Growth Fund highlighted stocks such as ICON Public Limited Company (NASDAQ:ICLR). Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ:ICLR) is a clinical research organization. The one-month return of ICON Public Limited Company (NASDAQ:ICLR) was 8.03%, and its shares lost 52.57% of their value over the last 52 weeks. On July 2, 2025, ICON Public Limited Company (NASDAQ:ICLR) stock closed at $150.82 per share, with a market capitalization of $11.988 billion. Parnassus Mid Cap Growth Fund stated the following regarding ICON Public Limited Company (NASDAQ:ICLR) in its Q1 2025 investor letter: "ICON Public Limited Company (NASDAQ:ICLR) is the second largest player in the clinical research organization (CRO) market due to competitive advantages created by its scale and long-standing customer relationships. We bought the stock after it sold off following delays in R&D spend in the biotech industry. With the stock trading at a low valuation on cyclically depressed earnings, we think ICON will benefit as R&D spend improves and as the company continues to gain market share." A laboratory setting with a team of scientists working on a clinical trial. ICON Public Limited Company (NASDAQ:ICLR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 44 hedge fund portfolios held ICON Public Limited Company (NASDAQ:ICLR) at the end of the first quarter, which was 46 in the previous quarter. ICON Public Limited Company's (NASDAQ:ICLR) first quarter revenue declined 4.3% year-over-year to $2 billion. While we acknowledge the potential of ICON Public Limited Company (NASDAQ:ICLR) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains. In another article, we covered ICON Public Limited Company (NASDAQ:ICLR) and shared Wasatch U.S. Select Strategy's views on the company. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of ICLR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
9 minutes ago
- Yahoo
ParaZero Receives a Recurring Bulk Order of SafeAir Systems from an Australian Distributor
Kfar Saba, Israel, July 03, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the 'company' or 'ParaZero'), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems today announced that it has received a follow-on order for its SafeAir™ drone safety systems from a leading Australian drone technology distributor. This new order specifically includes SafeAir™ systems for widely deployed DJI platforms across various commercial, law enforcement, search and rescue and other governmental sectors. This order follows the distributor's initial procurement in late 2024, which marked ParaZero's growing presence in the Australian market. The distributor continues to expand its offering of CASA-recognized SafeAir systems to meet increasing demand driven by evolving drone regulations and the need for safety-assured operations. ParaZero's SafeAir system is designed to autonomously detect flight anomalies and deploy a parachute in the event of failure, significantly reducing the risk of injury or damage. Operational safety credit granted by Civil Aviation Safety Authority (CASA) to operators specifically using the SafeAir System have made it a key enabler for commercial drone flights over or near people and populated areas across Australia. 'This follow-on order highlights the continued trust our partners place in ParaZero's safety technologies,' said Boaz Shetzer, CEO of ParaZero. 'The adoption of SafeAir for DJI's drones reflects the industry's growing focus on regulatory compliance and operational safety, especially for widely-used drone platforms.' About ParaZero Technologies ParaZero (Nasdaq: PRZO) is an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems. Started in 2014 by a passionate group of aviation professionals and drone industry veterans, ParaZero designs smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond-visual-line-of-sight (BVLOS) as well as for various military applications including Counter UAS. For more information about ParaZero, please visit Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as 'expects,' 'anticipates,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates' and similar expressions or variations of such words are intended to identify forward-looking statements. For example, ParaZero is using forward-looking statements when it discusses its growing presence in the Australian market, increasing demand driven by evolving drone regulations and the need for safety-assured operations and the drone industry's growing focus on regulatory compliance and operational safety, especially for widely-used drone platforms. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ('SEC'), including, but not limited to, the risks detailed in the Company's Annual Report on Form 20-F filed with the SEC on March 21, 2025. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. ParaZero is not responsible for the content of third-party websites. Investor Relations Contact: Michal Efraty Investor Relations michal@ ParaZero Technologies Ltd. | 1st HaTachana St. Kfar Saba, Israel 4453001 P: +972-502753666 | E: contact@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Miami Herald
11 minutes ago
- Miami Herald
As shoppers ditch Shein and Temu, these brands are winning
I'm not proud to admit it, but when I was younger, I had my fair share of Shein hauls. Some of the stuff I kept. A lot of it I never even wore. It was that cheap it didn't feel like I even spent real money. Since then, I've moved on. These days, I stay far away. Related: Nike's latest announcement has fans scratching their heads And apparently, I'm not the only one. Once the go-to for dirt-cheap fast fashion, Shein and Temu are starting to lose their grip on American shoppers. The TikTok hauls feel a little less frequent. The buzz isn't quite what it used to be. Behind the scenes, something bigger is happening - and it's starting to reshape where people shop next. Consumer spending at Shein and Temu took a steep hit this spring, and if you've been spending less on either site, you're not alone. According to Retail Dive, Shein saw more than a 10% drop in U.S. spending during the week ending May 11. Temu fell even harder, with a 20% decline. Neither brand has seen a major recovery since. The sharp pullback followed tariff hikes and rising trade tensions. Both brands initially announced price increases, then quickly walked them back - a sign of how sensitive their base is to even minor changes. As someone who used to shop at Shein, I get it. When the appeal is low prices, even a small bump makes people reconsider. Related: Why beauty will be the beast of Amazon Prime Day deals "I don't think we're going to see the levels [of spending on Shein and Temu] that we saw previously," said Ben Parkes of Similarweb. "In the U.S., we're going to see some rebalance." That rebalancing is already underway. Some of it is going to TikTok Shop and DHgate. But the real winners? More familiar names: Amazon, Zara, Asos. These are the brands quietly gaining as Shein and Temu struggle to hold their footing. Let's be honest - most people don't think of Amazon when they think fast fashion. But quietly, it's becoming a go-to. Over the past six months, Amazon's women's clothing category has grown over 26%, according to Similarweb. And while it might not scream "style hub," it's fast, it's cheap, and it delivers. That's a powerful combo - especially for shoppers burned out on delayed shipping and questionable quality. More on retail: The men's Lululemon rival you'll wish you discovered soonerTarget makes key move to copy Shein and Temu playbookA growing number of shoppers are avoiding this ingredient Even I've found myself scrolling Amazon for tank tops or basics I used to grab from Shein. It's not glamorous, but it works. The bigger shift, though, isn't just about Amazon. It's about what replaces the Shein-and-Temu haul mentality. Some shoppers are turning to department-store discounters like Nordstrom Rack. Others are drifting toward athleticwear brands like Columbia and Foot Locker. Even Aeropostale and American Eagle are seeing some lift. It's not about chasing the lowest price anymore. It's about trust, timing, and ease. Sure, Shein and Temu are pivoting to Europe and exploring U.S. fulfillment. But in the States, their era of dominance looks shakier than ever. For a generation of shoppers who once bragged about getting 12 tops for $40, priorities are shifting. And the retailers listening are the ones quietly winning. Related: Amazon's latest products go after a new type of customer The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.